AbbVie Inc. — LINZESS (Iinaclotide) · functional constipation (FC) in patients 2 to 5 ye.
Run-up into the decision (T-120 → T+5)
Daily close, T-120 (12/10/25) through T+5. Run-up high $236.19 on 3/6/26, low $197.38 on 4/28/26 (T-120 to T-1). FDA decision 5/27/26. Historical price action, not a forecast.